Press Release
New Study Shows 800%+ Spike in Searches to Move Abroad Post-Election — moveBuddha Reveals Where They Want to Go
Following the election, significant spikes in searches for moving out of America suggest heightened interest in international relocation. moveBuddha identifies the states with the highest interest in top international destinations and each state's top move-to country. Read More
Press Release
Aim Robotics Expands Into the United States With New Headquarters in Nashville, Tennessee, in Partnership With BlueBay Automation
Denmark-based Aim Robotics partners with BlueBay Automation to establish Aim Robotics US, bringing innovative dispensing solutions for collaborative robots closer to North American manufacturers. Read More
Press Release
ePropelled Delivers Hercules Starter Generator and Hybrid-Ready Power Solutions for More Uncrewed Vehicles
Rising demand for hybrid propulsion systems in military drones extends to adjacent vehicle markets adopting intelligent power management and compact generators. Rugged, compact, and powerful Hercules hybrid-ready propulsion solutions satisfy the need for extended range and mission agility for any uncrewed applications. Read More
Press Release
VoxAI Brings High-Performance Innovation and Efficiency to Professional Settings With the New Intelligent Voice Badge
Should professionals use bulky recording devices or opt for a compact, wearable solution? The Intelligent Voice Badge offers seamless documentation with cutting-edge AI technology. Read More
Press Release
Jaguar Health Reports Third Quarter 2024 Financial Results
The combined net Q3 2024 revenue of approximately $3.1 million for prescription and non-prescription products, including license revenue, increased approximately 14% versus net Q2 2024 revenue of $2.7 million and 11% versus net Q3 2023 revenue of $2.8 million Jaguar reported significant results in breast cancer patients in its phase 3 OnTarget trial for its cancer supportive care drug crofelemer; results in breast cancer patients accepted for poster presentation on December 11, 2024 at the San Antonio Breast Cancer Symposium (SABCS) Jaguar initiated commercial launch in October 2024 for Gelclair®, the company's third prescription product, in alignment with Jaguar's focus on cancer supportive care Jaguar is initiating two Phase 2 trials in Q4, 2024 and supporting multiple investigator-initiated proof-of-concept studies ("IIT") of crofelemer for the rare and orphan disease indications of microvillus inclusion disease (MVID) and short bowel syndrome (SBS) with intestinal failure in the US, EU, and Middle East/North Africa (MENA) regions; results of IITs expected by the end of 2024 and throughout 2025 REMINDER: Jaguar to host investor webcast Wednesday, November 13th at 8:30 a.m. Eastern regarding Q3 2024 financials and company updates; Click here to register for webcast Read More
Press Release
CBD Life Sciences Inc. (CBDL) Applies for Beer & Liquor License to Sell CBD Wine
Company is creating its own wine. Capitalizing on the projected $2.1 billion U.S. CBD-infused beverage market by 2025, CBDL positions itself at the forefront of innovation, unlocking immense revenue potential in the booming CBD alcohol sector. Read More
Press Release
CMTA and INC Forge Groundbreaking Alliance to Accelerate Comprehensive Research Across All Charcot-Marie-Tooth Disease Types
CMTA strengthens its role as the leading force in comprehensive CMT research, forging a new strategic alliance with the Inherited Neuropathy Consortium (INC) Together, CMTA and INC are driving research to accelerate the path toward effective treatments for every type of CMT Read More
Press Release
